dBET23 is primarily utilized in the field of biomedical research, particularly in the study of targeted protein degradation. It functions as a selective degrader of BET proteins, which are involved in the regulation of gene expression. By inducing the degradation of these proteins, dBET23 helps researchers investigate the roles of BET proteins in various cellular processes, including cancer progression and inflammation. This makes it a valuable tool for developing potential therapeutic strategies aimed at diseases where BET proteins play a critical role.